Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia touts study showing digital pathology software detected melanoma

Proscia
By Author Proscia | October 14, 2021

Study collaborator Dr. Kiran Motaparthi of the University of Florida and Julianna Ianni, Ph.D., Proscia’s Vice President of AI R&D, recently sat down with MedCity News to share their insight into our AI breakthrough on melanoma detection.

Our website uses cookies. By using this site, you agree to its use of cookies.